{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:42:17Z","timestamp":1794948137344,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["AGAUR 2018 FIB00696"],"award-info":[{"award-number":["AGAUR 2018 FIB00696"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Suport de Grups de Recerca AGAUR","award":["2021-SGR-01293"],"award-info":[{"award-number":["2021-SGR-01293"]}]},{"name":"Suport de Grups de Recerca AGAUR","award":["2021-SGR-01172"],"award-info":[{"award-number":["2021-SGR-01172"]}]},{"DOI":"10.13039\/501100003741","name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","doi-asserted-by":"publisher","award":["Academia Researcher"],"award-info":[{"award-number":["Academia Researcher"]}],"id":[{"id":"10.13039\/501100003741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003741","name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","doi-asserted-by":"publisher","award":["Academia Researcher"],"award-info":[{"award-number":["Academia Researcher"]}],"id":[{"id":"10.13039\/501100003741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["\"Una manera de hacer Europa\" PID2021-123054OB-I00"],"award-info":[{"award-number":["\"Una manera de hacer Europa\" PID2021-123054OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201920-30"],"award-info":[{"award-number":["201920-30"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>MALAT1<\/jats:italic> long non-coding RNA has oncogenic roles but has been poorly studied in indolent B-cell neoplasms. Here, <jats:italic>MALAT1<\/jats:italic> expression was analyzed using RNA-seq, microarrays or qRT-PCR in primary samples from clinico-biological subtypes of chronic lymphocytic leukemia (CLL, n\u2009=\u2009266), paired Richter transformation (RT, n\u2009=\u20096) and follicular lymphoma (FL, n\u2009=\u200961). In peripheral blood (PB) CLL samples, high <jats:italic>MALAT1<\/jats:italic> expression was associated with a significantly shorter time to treatment independently from other known prognostic factors. Coding genes expressed in association with <jats:italic>MALAT1<\/jats:italic> in CLL were predominantly related to oncogenic pathways stimulated in the lymph node (LN) microenvironment. In RT paired samples, <jats:italic>MALAT1<\/jats:italic> levels were lower, concordant with their acquired increased independency of external signals. Moreover, <jats:italic>MALAT1<\/jats:italic> levels in paired PB\/LN CLLs were similar, suggesting that the prognostic value of <jats:italic>MALAT1<\/jats:italic> expression in PB is mirroring expression differences already present in LN. Similarly, high <jats:italic>MALAT1<\/jats:italic> expression in FL predicted for a shorter progression-free survival, in association with expression pathways promoting FL pathogenesis. In summary, <jats:italic>MALAT1<\/jats:italic> expression is related to pathophysiology and more aggressive clinical behavior of indolent B-cell neoplasms. Particularly in CLL, its levels could be a surrogate marker of the microenvironment stimulation and may contribute to refine the clinical management of these patients.<\/jats:p>","DOI":"10.1038\/s41598-023-44174-8","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T09:02:07Z","timestamp":1696582927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms"],"prefix":"10.1038","volume":"13","author":[{"given":"Elena Mar\u00eda","family":"Fern\u00e1ndez-Garnacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mozas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"L\u00f3pez-Guillermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00ed","family":"Duran-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Salaverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Demajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Jares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xose S.","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Mart\u00edn-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4854-3069","authenticated-orcid":false,"given":"Llu\u00eds","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"44174_CR1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s13105-012-0166-y","volume":"68","author":"Y Huang","year":"2012","unstructured":"Huang, Y. et al. Regulatory long non-coding RNA and its functions. J. Physiol. Biochem. 68, 611\u2013618 (2012).","journal-title":"J. Physiol. Biochem."},{"key":"44174_CR2","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan, A., Soleimani, M. & Mandal, S. S. Long noncoding RNA and cancer: A new paradigm. Cancer Res. 77, 3965\u20133981 (2017).","journal-title":"Cancer Res."},{"key":"44174_CR3","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.2147\/CMAR.S169406","volume":"10","author":"Z-X Li","year":"2018","unstructured":"Li, Z.-X. et al. MALAT1: A potential biomarker in cancer. Cancer Manag. Res. 10, 6757\u20136768 (2018).","journal-title":"Cancer Manag. Res."},{"key":"44174_CR4","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/15476286.2017.1358347","volume":"14","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Hamblin, M. H. & Yin, K.-J. The long noncoding RNA Malat 1: Its physiological and pathophysiological functions. RNA Biol. 14, 1705\u20131714 (2017).","journal-title":"RNA Biol."},{"key":"44174_CR5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.7150\/jca.14663","volume":"7","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. The long noncoding RNA MALAT-1 is a novel biomarker in various cancers: A meta-analysis based on the GEO database and literature. J. Cancer 7, 991\u20131001 (2016).","journal-title":"J. Cancer"},{"key":"44174_CR6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ijc.31386","volume":"143","author":"ZH Kwok","year":"2018","unstructured":"Kwok, Z. H., Roche, V., Chew, X. H., Fadieieva, A. & Tay, Y. A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers. Int. J. Cancer 143, 668\u2013678 (2018).","journal-title":"Int. J. Cancer"},{"key":"44174_CR7","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim, J. et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat. Genet. 50, 1705\u20131715 (2018).","journal-title":"Nat. Genet."},{"key":"44174_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12943-017-0580-4","volume":"16","author":"M Zhou","year":"2017","unstructured":"Zhou, M. et al. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma. Mol. Cancer 16, 16 (2017).","journal-title":"Mol. Cancer"},{"key":"44174_CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjh.15656","volume":"184","author":"A Roisman","year":"2019","unstructured":"Roisman, A. et al. Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomas. Br. J. Haematol. 184, 373\u2013383 (2019).","journal-title":"Br. J. Haematol."},{"key":"44174_CR10","volume":"231","author":"Q-M Wang","year":"2019","unstructured":"Wang, Q.-M., Lian, G.-Y., Song, Y., Huang, Y.-F. & Gong, Y. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 231, 116335 (2019).","journal-title":"Life Sci."},{"key":"44174_CR11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5045\/br.2018.53.4.320","volume":"53","author":"A Ahmadi","year":"2018","unstructured":"Ahmadi, A. et al. Altered expression of MALAT1 lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings. Blood Res. 53, 320\u2013324 (2018).","journal-title":"Blood Res."},{"key":"44174_CR12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-016-1100-9","volume":"14","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2. J. Transl. Med. 14, 346 (2016).","journal-title":"J. Transl. Med."},{"key":"44174_CR13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519\u2013524 (2015).","journal-title":"Nature"},{"key":"44174_CR14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1741-7015-11-124","volume":"11","author":"V Quesada","year":"2013","unstructured":"Quesada, V. et al. The genomic landscape of chronic lymphocytic leukemia: Clinical implications. BMC Med. 11, 124 (2013).","journal-title":"BMC Med."},{"key":"44174_CR15","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood.2020008311","volume":"137","author":"F Nadeu","year":"2020","unstructured":"Nadeu, F. et al. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics. Blood 137, 2935\u20132946 (2020).","journal-title":"Blood"},{"key":"44174_CR16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s43018-020-00131-2","volume":"1","author":"M Duran-Ferrer","year":"2020","unstructured":"Duran-Ferrer, M. et al. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome. Nat. Cancer 1, 1066\u20131081 (2020).","journal-title":"Nat. Cancer"},{"key":"44174_CR17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1158\/0008-5472.CAN-18-0781","volume":"79","author":"EL Dadashian","year":"2019","unstructured":"Dadashian, E. L. et al. TLR signaling is activated in lymph node-resident CLL cells and is only partially inhibited by ibrutinib. Cancer Res 79, 360\u2013371 (2019).","journal-title":"Cancer Res"},{"key":"44174_CR18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2119\/molmed.2012.00303","volume":"20","author":"AK Mittal","year":"2014","unstructured":"Mittal, A. K. et al. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease. Mol. Med. 20, 290\u2013301 (2014).","journal-title":"Mol. Med."},{"key":"44174_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5603\/FHC.a2020.0006","volume":"58","author":"W Kowalska","year":"2020","unstructured":"Kowalska, W. & Bojarska-Junak, A. Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment. Folia Histochem. Cytobiol. 58, 25\u201336 (2020).","journal-title":"Folia Histochem. Cytobiol."},{"key":"44174_CR20","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.3390\/ijms19082396","volume":"19","author":"S Mirabilii","year":"2018","unstructured":"Mirabilii, S. et al. Biological aspects of mTOR in leukemia. Int. J. Mol. Sci. 19, 2396 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"44174_CR21","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1182\/bloodadvances.2017015560","volume":"2","author":"L Lezina","year":"2018","unstructured":"Lezina, L. et al. CD40L\/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM. Blood Adv. 2, 1869\u20131881 (2018).","journal-title":"Blood Adv."},{"key":"44174_CR22","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1080\/10428194.2017.1370548","volume":"59","author":"A Shukla","year":"2018","unstructured":"Shukla, A., Shukla, V. & Joshi, S. S. Regulation of MAPK signaling and implications in chronic lymphocytic leukemia. Leuk. Lymphoma 59, 1565\u20131573 (2018).","journal-title":"Leuk. Lymphoma"},{"key":"44174_CR23","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.3390\/ijms22115868","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang, N., Coutinho, L. E. & Pati, D. PDS5A and PDS5B in cohesin function and human disease. Int. J. Mol. Sci. 22, 5868 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"44174_CR24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/hmg\/ddt436","volume":"23","author":"HM Moon","year":"2014","unstructured":"Moon, H. M. et al. LIS1 controls mitosis and mitotic spindle organization via the LIS1-NDEL1-dynein complex. Hum. Mol. Genet. 23, 449\u2013466 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"44174_CR25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.lungcan.2012.05.105","volume":"77","author":"F-Y Lo","year":"2012","unstructured":"Lo, F.-Y., Chen, H.-T., Cheng, H.-C., Hsu, H.-S. & Wang, Y.-C. Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer. Lung Cancer 77, 585\u2013592 (2012).","journal-title":"Lung Cancer"},{"key":"44174_CR26","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1158\/0008-5472.CAN-18-3297","volume":"79","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. NFAT1-Mediated regulation of NDEL1 promotes growth and invasion of glioma stem-like cells. Cancer Res. 79, 2593\u20132603 (2019).","journal-title":"Cancer Res."},{"key":"44174_CR27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/10428194.2015.1068308","volume":"57","author":"EM Hartmann","year":"2016","unstructured":"Hartmann, E. M., Rudelius, M., Burger, J. A. & Rosenwald, A. CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates. Leuk. Lymphoma 57, 563\u2013571 (2016).","journal-title":"Leuk. Lymphoma"},{"key":"44174_CR28","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0002-9440(10)61244-8","volume":"167","author":"P Secchiero","year":"2005","unstructured":"Secchiero, P. et al. Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. Am. J. Pathol. 167, 1599\u20131607 (2005).","journal-title":"Am. J. Pathol."},{"key":"44174_CR29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/1541-7786.MCR-09-0391","volume":"8","author":"H-W Lo","year":"2010","unstructured":"Lo, H.-W., Cao, X., Zhu, H. & Ali-Osman, F. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol. Cancer Res. 8, 232\u2013245 (2010).","journal-title":"Mol. Cancer Res."},{"key":"44174_CR30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","volume":"6","author":"RL Carpenter","year":"2014","unstructured":"Carpenter, R. L. & Lo, H.-W. STAT3 target genes relevant to human cancers. Cancers (Basel) 6, 897\u2013925 (2014).","journal-title":"Cancers (Basel)"},{"key":"44174_CR31","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.0802655105","volume":"105","author":"S Wee","year":"2008","unstructured":"Wee, S. et al. PTEN-deficient cancers depend on PIK3CB. Proc. Natl. Acad. Sci. U. S. A. 105, 13057\u201313062 (2008).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"44174_CR32","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1101\/gad.1690808","volume":"22","author":"KJ Mavrakis","year":"2008","unstructured":"Mavrakis, K. J. et al. Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Genes Dev. 22, 2178\u20132188 (2008).","journal-title":"Genes Dev."},{"key":"44174_CR33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.gene.2018.08.048","volume":"678","author":"M Hu","year":"2018","unstructured":"Hu, M., Liu, L. & Yao, W. Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells. Gene 678, 261\u2013269 (2018).","journal-title":"Gene"},{"key":"44174_CR34","doi-asserted-by":"crossref","first-page":"eabi6439","DOI":"10.1126\/sciadv.abi6439","volume":"7","author":"Q Cai","year":"2021","unstructured":"Cai, Q. et al. MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockade. Sci. Adv. 7, eabi6439 (2021).","journal-title":"Sci. Adv."},{"key":"44174_CR35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12860-020-00278-x","volume":"21","author":"A Horv\u00e1th","year":"2020","unstructured":"Horv\u00e1th, A., Rona, G., Pagano, M. & Jordan, P. W. Interaction between NSMCE4A and GPS1 links the SMC5\/6 complex to the COP9 signalosome. BMC Mol. Cell Biol. 21, 36 (2020).","journal-title":"BMC Mol. Cell Biol."},{"key":"44174_CR36","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/j.1582-4934.2012.01574.x","volume":"16","author":"Z Wang","year":"2012","unstructured":"Wang, Z., Potter, C. S., Sundberg, J. P. & Hogenesch, H. SHARPIN is a key regulator of immune and inflammatory responses. J. Cell Mol. Med. 16, 2271\u20132279 (2012).","journal-title":"J. Cell Mol. Med."},{"key":"44174_CR37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/nsmb1306","volume":"14","author":"F Mantovani","year":"2007","unstructured":"Mantovani, F. et al. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat. Struct. Mol. Biol. 14, 912\u2013920 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"44174_CR38","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","volume":"28","author":"F Nadeu","year":"2022","unstructured":"Nadeu, F. et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat. Med. 28, 1662\u20131671 (2022).","journal-title":"Nat. Med."},{"key":"44174_CR39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","volume":"117","author":"Y Herishanu","year":"2011","unstructured":"Herishanu, Y. et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117, 563\u2013574 (2011).","journal-title":"Blood"},{"key":"44174_CR40","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2010.223","volume":"24","author":"C Pangault","year":"2010","unstructured":"Pangault, C. et al. Follicular lymphoma cell niche: Identification of a preeminent IL-4-dependent T(FH)-B cell axis. Leukemia 24, 2080\u20132089 (2010).","journal-title":"Leukemia"},{"key":"44174_CR41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2018.07.005","volume":"45","author":"J Devan","year":"2018","unstructured":"Devan, J., Janikova, A. & Mraz, M. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs. Semin. Oncol. 45, 291\u2013302 (2018).","journal-title":"Semin. Oncol."},{"key":"44174_CR42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/cancers13040630","volume":"13","author":"K Du\u015b-Szachniewicz","year":"2021","unstructured":"Du\u015b-Szachniewicz, K., Rymkiewicz, G., Agrawal, A. K., Ko\u0142odziej, P. & Wi\u015bniewski, J. R. Large-scale proteomic analysis of follicular lymphoma reveals extensive remodeling of cell adhesion pathway and identifies hub proteins related to the lymphomagenesis. Cancers (Basel) 13, 630 (2021).","journal-title":"Cancers (Basel)"},{"key":"44174_CR43","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.7150\/jca.11279","volume":"6","author":"T Dong","year":"2015","unstructured":"Dong, T. et al. The expression of CD9 and PIK3CD is associated with prognosis of follicular lymphoma. J. Cancer 6, 1222\u20131229 (2015).","journal-title":"J. Cancer"},{"key":"44174_CR44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ni893","volume":"4","author":"K Saijo","year":"2003","unstructured":"Saijo, K. et al. Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nat. Immunol. 4, 274\u2013279 (2003).","journal-title":"Nat. Immunol."},{"key":"44174_CR45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ejh.12427","volume":"94","author":"V Seda","year":"2015","unstructured":"Seda, V. & Mraz, M. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. Eur. J. Haematol. 94, 193\u2013205 (2015).","journal-title":"Eur. J. Haematol."},{"key":"44174_CR46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3892\/ijo.2013.1867","volume":"42","author":"Y-J Lee","year":"2013","unstructured":"Lee, Y.-J. et al. Prognostic value of CAPZA1 overexpression in gastric cancer. Int. J. Oncol. 42, 1569\u20131577 (2013).","journal-title":"Int. J. Oncol."},{"key":"44174_CR47","doi-asserted-by":"crossref","first-page":"1025192","DOI":"10.3389\/fonc.2022.1025192","volume":"12","author":"T Qin","year":"2022","unstructured":"Qin, T. et al. NcRNA-regulated CAPZA1 associated with prognostic and immunological effects across lung adenocarcinoma. Front. Oncol. 12, 1025192 (2022).","journal-title":"Front. Oncol."},{"key":"44174_CR48","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3109\/0886022X.2015.1061887","volume":"37","author":"F Fu","year":"2015","unstructured":"Fu, F., Wei, X., Liu, J. & Mi, N. Bioinformatic analysis of specific genes in diabetic nephropathy. Ren. Fail. 37, 1219\u20131224 (2015).","journal-title":"Ren. Fail."},{"key":"44174_CR49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","volume":"570","author":"AD Zuehlke","year":"2015","unstructured":"Zuehlke, A. D., Beebe, K., Neckers, L. & Prince, T. Regulation and function of the human HSP90AA1 gene. Gene 570, 8\u201316 (2015).","journal-title":"Gene"},{"key":"44174_CR50","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.3390\/cancers12102865","volume":"12","author":"C Pangault","year":"2020","unstructured":"Pangault, C. et al. Integrative analysis of cell crosstalk within follicular lymphoma cell niche: Towards a definition of the FL supportive synapse. Cancers (Basel) 12, 2865 (2020).","journal-title":"Cancers (Basel)"},{"key":"44174_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2141.2006.06255.x","volume":"135","author":"A Harjunp\u00e4\u00e4","year":"2006","unstructured":"Harjunp\u00e4\u00e4, A. et al. Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP. Br. J. Haematol. 135, 33\u201342 (2006).","journal-title":"Br. J. Haematol."},{"key":"44174_CR52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333\u2013339 (2013).","journal-title":"Nature"},{"key":"44174_CR53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"E Rheinbay","year":"2020","unstructured":"Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102\u2013111 (2020).","journal-title":"Nature"},{"key":"44174_CR54","first-page":"15903","volume":"8","author":"F Guo","year":"2015","unstructured":"Guo, F., Guo, L., Li, Y., Zhou, Q. & Li, Z. MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation. Int. J. Clin. Exp. Pathol. 8, 15903\u201315910 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"44174_CR55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2018.08.009","volume":"436","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. TGF-\u03b2-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1\/miR-30a interactions. Cancer Lett. 436, 52\u201362 (2018).","journal-title":"Cancer Lett."},{"key":"44174_CR56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/ijms20010098","volume":"20","author":"T Zheng","year":"2018","unstructured":"Zheng, T., Ma, G., Tang, M., Li, Z. & Xu, R. IL-8 secreted from M2 macrophages promoted prostate tumorigenesis via STAT3\/MALAT1 pathway. Int. J. Mol. Sci. 20, 98 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"44174_CR57","doi-asserted-by":"crossref","first-page":"793","DOI":"10.21873\/invivo.11541","volume":"33","author":"C-H Hong","year":"2019","unstructured":"Hong, C.-H., Lin, S.-H. & Lee, C.-H. CCL21 induces mTOR-dependent MALAT1 expression, leading to cell migration in cutaneous T-cell lymphoma. In Vivo 33, 793\u2013800 (2019).","journal-title":"In Vivo"},{"key":"44174_CR58","first-page":"302","volume":"21","author":"Y-T Zhuang","year":"2017","unstructured":"Zhuang, Y.-T. et al. IL-6 induced lncRNA MALAT1 enhances TNF-\u03b1 expression in LPS-induced septic cardiomyocytes via activation of SAA3. Eur. Rev. Med. Pharmacol. Sci. 21, 302\u2013309 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"44174_CR59","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood.2020010029","volume":"138","author":"FK Stevenson","year":"2021","unstructured":"Stevenson, F. K., Forconi, F. & Kipps, T. J. Exploring the pathways to chronic lymphocytic leukemia. Blood 138, 827\u2013835 (2021).","journal-title":"Blood"},{"key":"44174_CR60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbamcr.2015.07.009","volume":"1863","author":"E Ten Hacken","year":"2016","unstructured":"Ten Hacken, E. & Burger, J. A. Microenvironment interactions and B-cell receptor signaling in chronic lymphocytic leukemia: Implications for disease pathogenesis and treatment. Biochim. Biophys. Acta 1863, 401\u2013413 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"44174_CR61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41591-022-02113-6","volume":"29","author":"EM Parry","year":"2023","unstructured":"Parry, E. M. et al. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nat. Med. 29, 158\u2013169 (2023).","journal-title":"Nat. Med."},{"key":"44174_CR62","first-page":"22","volume":"6","author":"G Arun","year":"2020","unstructured":"Arun, G., Aggarwal, D. & Spector, D. L. MALAT1 long non-coding RNA: Functional implications. Noncoding RNA 6, 22 (2020).","journal-title":"Noncoding RNA"},{"key":"44174_CR63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yexcr.2010.09.011","volume":"317","author":"S Tauzin","year":"2011","unstructured":"Tauzin, S., Ding, H., Burdevet, D., Borisch, B. & Hoessli, D. C. Membrane-associated signaling in human B-lymphoma lines. Exp. Cell Res. 317, 151\u2013162 (2011).","journal-title":"Exp. Cell Res."},{"key":"44174_CR64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1101\/gr.152132.112","volume":"24","author":"PG Ferreira","year":"2014","unstructured":"Ferreira, P. G. et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 24, 212\u2013226 (2014).","journal-title":"Genome Res."},{"key":"44174_CR65","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis, M. et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat. Genet. 44, 1236\u20131242 (2012).","journal-title":"Nat. Genet."},{"key":"44174_CR66","first-page":"64","volume":"45","author":"D Potashnikova","year":"2015","unstructured":"Potashnikova, D., Gladkikh, A. & Vorobjev, I. A. Selection of superior reference genes\u2019 combination for quantitative real-time PCR in B-cell lymphomas. Ann. Clin. Lab. Sci. 45, 64\u201372 (2015).","journal-title":"Ann. Clin. Lab. Sci."},{"key":"44174_CR67","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/his.12035","volume":"62","author":"K Yagi","year":"2013","unstructured":"Yagi, K. et al. Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells. Histopathology 62, 414\u2013420 (2013).","journal-title":"Histopathology"},{"key":"44174_CR68","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44174-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44174-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44174-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T21:59:59Z","timestamp":1700258399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44174-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44174"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-44174-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16839"}}